Antihypertensive treatment and risk of dementia: A retrospective database study

International Journal of Clinical Pharmacology and Therapeutics

Volumn 50, Issue 3, 2012, Pages 195-201

  Wagner, Gabriele ^b   Icks, Andrea ^a   Abholz, Heinz Harald ^b   Schrod̈er Bernhardi, Detlef ^c   Rathmann, Wolfgang ^a   Kostev, Karel ^c  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c IQVIA   (United States)

Author keywords

ACE inhibitors; Beta blockers; Dementia; Hypertension

Indexed keywords

ANGIOTENSIN I; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGED; ARTICLE; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG MECHANISM; FEMALE; HEALTH CARE UTILIZATION; HEART FAILURE; HUMAN; HYPERTENSION; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT; STROKE;

ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CASE-CONTROL STUDIES; DATABASES, FACTUAL; DEMENTIA; FEMALE; HUMANS; LOGISTIC MODELS; MALE; NEUROPROTECTIVE AGENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84857463706     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CP201284     Document Type: Article

References (46)

1. Semplicini A, Inverso G. Antihypertensive treatment and cognitive function: another tempest in a P pot? J Hypertens. 2008; 26: 1551-1552. doi:10.1097/HJH.0b013e328306a72d PubMed
2. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347: 1141-1145. doi:10.1016/S0140-6736(96) 90608-X PubMed (Pubitemid 126512042)
3. Waldstein SR, Giggey PP, Thayer JF, Zonderman AB. Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging. Hypertension. 2005; 45: 374-379. doi:10.1161/01.HYP.0000156744.44218.74 PubMed (Pubitemid 40315806)
4. McGuinness B, B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia: The Cochrane Collaboration. The Cochrane Library 2007, Issue 3.
5. Li G, Rhew IC, Shofer JB, Kukull WA, Breitner JC, Peskind E, Bowen JD, McCormick W, Teri L, Crane PK, Larson EB. Age-varying association between blood pressure and risk of dementia in those aged 65 and older: a community-based prospective cohort study. J Am Geriatr Soc. 2007; 55: 1161-1167. doi:10.1111/j.1532-5415.2007.01233.x PubMed (Pubitemid 47106671)
6. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults. BMJ. 1996; 312: 801-805. PubMed (Pubitemid 26099297)
7. Maxwell CJ, Hogan DB, Ebly EM. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging. CMAJ. 1999; 161: 501-506. PubMed (Pubitemid 29433523)
8. Murray MD, Lane KA, Gao S, Evans RM, Unverzagt FW, Hall KS, Hendrie H. Preservation of cognitive function with antihypertensive medications: a longitudinal analysis of a community-based sample of African Americans. Arch Intern Med. 2002; 162: 2090-2096. doi:10.1001/archinte.162.18.2090 PubMed (Pubitemid 35168217)
9. Hanon O, Seux ML, Lenoir H, Rigaud AS, Forette F. Prevention of dementia and cerebroprotection with antihypertensive drugs. Curr Hypertens Rep. 2004; 6: 201-207. doi:10.1007/s11906-004-0070-0 PubMed (Pubitemid 39359563)
10. Hanon O, Pequignot R, Seux ML, Lenoir H, Bune A, Rigaud AS, Forette F, Girerd X. Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints. J Hypertens. 2006; 24: 2101-2107. doi:10.1097/01.hjh.0000244961.69985.05 PubMed (Pubitemid 44371278)
11. Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006; 37: 1165-1170. doi:10.1161/01.STR.0000217653.01615.93 PubMed (Pubitemid 43731856)
12. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265: 3255-3264. doi:10.1001/jama.265.24.3255 PubMed
13. Applegate WB, Pressel S, Wittes J, Luhr J, Shekelle RB, Camel GH, Greenlick MR, Hadley E, Moye L, Perry HM Jr et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Arch Intern Med. 1994; 154: 2154-2160. doi:10.1001/archinte.154.19.2154 PubMed (Pubitemid 24317261)
14. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998; 352: 1347-1351. doi:10.1016/S0140-6736(98)03086-4 PubMed (Pubitemid 28510916)
15. Forette F, Seux ML, Staessen JA et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (SystEur) Study. Arch Intern Med. 2002; 162: 2046-2052. (Pubitemid 35168212)
16. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003; 21: 875-886. doi:10.1097/00004872- 200305000-00011 PubMed (Pubitemid 36677151)
17. Degl'Innocenti A, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A, Wiklund I; DeglÍnnocenti A. Health-related quality of life during treatment of elderly patients with hypertension: results from the Study on Cognition and Prognosis in the Elderly (SCOPE). J Hum Hypertens. 2004; 18: 239-245. doi:10.1038/sj.jhh.1001657 PubMed
18. Bots ML, Witteman JC, Hofman A, de Jong PT, Grobbee DE. Low diastolic blood pressure and atherosclerosis in elderly subjects. The Rotterdam study. Arch Intern Med. 1996; 156: 843-848. doi:10.1001/archinte.156.8.843 PubMed (Pubitemid 26119811)
19. in't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging. 2001; 22: 407-412. doi:10.1016/S0197-4580(00)00241-4 PubMed
20. Ruitenberg A, Skoog I, Ott A et al. Antihypertensive drugs and incidence of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord. 2001; 12: 33-39. PubMed doi:10.1159/000051233
21. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996; 312: 805-808. PubMed (Pubitemid 26099298)
22. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Arch Neurol. 2003; 60: 223-228. doi:10.1001/archneur.60.2.223 PubMed (Pubitemid 36193966)
23. Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA. 1999; 281: 438-445. doi:10.1001/jama.281.5.438 PubMed (Pubitemid 29069442)
24. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 2002; 156: 445-453. doi:10.1093/aje/kwf074 PubMed (Pubitemid 34976983)
25. Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, Chalmers J; PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003; 163: 1069-1075. doi:10.1001/archinte.163.9.1069 PubMed (Pubitemid 36548935)
26. Yasar S, Corrada M, Brookmeyer R, Kawas C. Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging. Neurobiol Aging. 2005; 26: 157-163. doi:10.1016/j.neurobiolaging.2004.03.009 PubMed (Pubitemid 39600576)
27. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC. Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol. 2006; 63: 686-692. doi:10.1001/archneur.63.5.noc60013 PubMed
28. Peters R, Beckett N, Forette F, Tuomilehto J, Clarke R, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C; HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol. 2008; 7: 683-689. doi:10.1016/S1474-4422(08)70143-1 PubMed
29. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci. 2005; 229-230: 151-155. doi:10.1016/j.jns.2004.11.020 PubMed (Pubitemid 40341579)
30. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005; 4: 487-499. doi:10.1016/S1474-4422(05)70141-1 PubMed (Pubitemid 40982459)
31. Richards SS, Emsley CL, Roberts J, Murray MD, Hall K, Gao S, Hendrie HC. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J Am Geriatr Soc. 2000; 48: 1035-1041. PubMed
32. Cacciatore F, Abete P, Ferrara N, Paolisso G, Amato L, Canonico S, Maggi S, Varricchio M, Rengo F; Osservatorio Geriatrico Campano Group. The role of blood pressure in cognitive impairment in an elderly population. J Hypertens. 1997; 15: 135-142. doi:10.1097/00004872-199715020-00003 PubMed (Pubitemid 27118588)
33. Heckbert SR, Longstreth WT Jr, Psaty BM, Murros KE, Smith NL, Newman AB, Williamson JD, Bernick C, Furberg CD. The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc. 1997; 45: 1423-1433. PubMed (Pubitemid 127747111)
34. Rathmann W, Haastert B, Roseman JM, Gries FA, Giani G. Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care. 1998; 21: 389-397. doi:10.2337/diacare.21.3.389 PubMed (Pubitemid 28101074)
35. Dietlein G, Schröder-Bernhardi D. Use of the mediplus patient database in healthcare research. Int J Clin Pharmacol Ther. 2002; 40: 130-133. PubMed (Pubitemid 34211283)
36. Rathmann W, Haastert B, Icks A, Giani G. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004. Diabetes Care. 2007; 30: 848-853. doi:10.2337/dc06-2000 PubMed (Pubitemid 46556576)
37. Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, Breitner JC, Munger R, Lyketsos CG. Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am J Geriatr Psychiatry. 2008; 16: 883-892. doi:10.1097/JGP. 0b013e318181276a PubMed
38. Rosenberg PB. Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry. 2005; 17: 503-514. doi:10.1080/02646830500382037 PubMed (Pubitemid 43086677)
39. Savitz SI, Erhardt JA, Anthony JV, Gupta G, Li X, Barone FC, Rosenbaum DM. The novel beta-blocker, carvedilol, provides neuroprotection in transient focal stroke. J Cereb Blood Flow Metab. 2000; 20: 1197-1204. doi:10.1097/00004647-2000 08000-00005 PubMed
40. Yasra S, Zhou J, Varadhan R, Carlson M. C. The use of angiotensin-converting enzyme inhibitors and diuretics is associated with a reduced incidence of impairment on cognition in elderly women. CPT. 2008; 84: 119-126. (Pubitemid 351861493)
41. Savaskan E. The role of the brain renin-angiotensin system in neurodegenerative disorders. Curr Alzheimer Res. 2005; 2: 29-35. doi:10.2174/1567205052772740 PubMed (Pubitemid 41389257)
42. Kehoe PG, Wilcock GK. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol. 2007; 6: 373-378. doi:10.1016/S1474-4422(07)70077-7 PubMed (Pubitemid 46389616)
43. Lipsitz LA, Gagnon M, Vyas M, Iloputaife I, Kiely DK, Sorond F, Serrador J, Cheng DM, Babikian V, Cupples LA. Antihypertensive therapy increases cerebral blood flow and carotid distensibility in hypertensive elderly subjects. Hypertension. 2005; 45: 216-221. doi:10.1161/01.HYP.0000153094.09615.11 PubMed (Pubitemid 40179963)
44. Cesari M, Kritchevsky SB, Baumgartner RN, Atkinson HH, Penninx BW, Lenchik L, Palla SL, Ambrosius WT, Tracy RP, Pahor M. Sarcopenia, obesity, and inflammation - results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study. Am J Clin Nutr. 2005; 82: 428-434. PubMed
45. von Haehling S, Sandek A, Anker SD. Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapy. J Am Geriatr Soc. 2005; 53: 2030-2031. doi:10.111 1/j.1532-5415.2005.53571.x PubMed
46. Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser MG, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N, Tzourio C; PROGRESS MRI Substudy Investigators. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation. 2005; 112: 1644-1650. doi:10.1161/CIRCULATIONAHA. 104.501163 PubMed (Pubitemid 41324527)